What’s Happening With Axsome Therapeutics Stock?

What’s Happening With Axsome Therapeutics Stock?

Last month we discussed that Axsome Therapeutics stock is likely to continue to see higher levels after it rose 6% in a week following the U.S. FDA’s acceptance of a new drug application for the company’s migraine drug – AXS-07. AXSM stock has since then rallied 27% to levels of nearly $38 now…